Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
37,972,605
-
Total 13F shares
-
35,261,080
-
Share change
-
+960,792
-
Total reported value
-
$723,422,287
-
Put/Call ratio
-
19%
-
Price per share
-
$20.60
-
Number of holders
-
143
-
Value change
-
-$10,851,198
-
Number of buys
-
91
-
Number of sells
-
61
Institutional Holders of iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) as of Q2 2022
As of 30 Jun 2022,
iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) was held by
143 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,261,080 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., MPM ASSET MANAGEMENT LLC, STATE STREET CORP, BOXER CAPITAL, LLC, BVF INC/IL, BIOIMPACT CAPITAL LLC, VANGUARD GROUP INC, TANG CAPITAL MANAGEMENT LLC, and Rubric Capital Management LP.
This page lists
141
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.